To learn more about our clinical trials, patient advocacy initiatives or to discuss ways to collaborate, please contact us at: +1 781-384-2053 or med.info@agenusbio.com.
Botensilimab from Agenus is being studied in 10 research trials at 53 universities and hospitals. Currently, all trials are closed to new participants. Please check back to find out if this has changed. Learn about compassionate use/expanded access.
Agenus is committed to providing support for Investigator Sponsored Trials (ISTs). Investigators can find more information and submit a proposal via the Agenus IST Portal
Agenus is committed to making our investigational medicines available to patients with cancer. Our goal is to provide access to our investigational medicines at the appropriate time and in the correct manner for patients. You can find information on access and apply.
For SAEs, regardless of attribution, the investigator must notify Agenus immediately (i.e., ≤24 hours after becoming aware) via e-mail on an SAE report form provided by Agenus and later send the MedWatch FDA F3500A used for submission to FDA by fax or e-mail:
By electronic media (Adverse.Events@Agenusbio.com)
Or
Paper (Fax: +1-781-674-4261)
The Investigator’s assessment of an AEs relationship to the study medication will be included on the SAE report submitted to drug manufacturer. For overdoses associated with a SAE, standard reporting timelines apply.
Reporting procedures and timelines are the same for any new information on a previously reported SAE or pregnancy (= follow-up).
We will do our best to accommodate your request for a meeting. If for any reason it should not be possible to meet during the conference, we will follow up immediately after the conference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 781.674.4400 | F: +1 781.674.4200
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.